Skip to content

13F-HR filed by Mirabaud Asset Management (France) SAS

Mirabaud Asset Management (France) SAS filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-13, with 9 holding rows worth $86,098,705.

Accession
0002033031-25-000001
Filed
2025-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 9 entries on the cover page, a total value of $86,098,705 stated on the cover page (in dollars after the unit check, H1), rows summing to $86,098,705 with VALUE read as dollars as filed, 13F file number 028-24292. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LI AUTO INC50202MAB8NOTE 0.250% 5/014,450,000$16,747,546dollars as filedprincipal
EQUINOX GOLD CORP29446YAC0NOTE 4.750%10/114,820,000$16,362,433dollars as filedprincipal
RAPID7 INC753422AH7NOTE 1.250% 3/112,100,000$11,656,784dollars as filedprincipal
HALOZYME THERAPEUTICS INC40637HAF6NOTE 1.000% 8/17,950,000$8,633,285dollars as filedprincipal
SEAGATE HDD CAYMAN81180WBL4NOTE 3.500% 6/06,700,000$8,138,133dollars as filedprincipal
AKAMAI TECHNOLOGIES INC00971TAJ0NOTE 0.125% 5/07,500,000$7,991,838dollars as filedprincipal
ALNYLAM PHARMACEUTICALS INC02043QAB3NOTE 1.000% 9/15,200,000$5,566,831dollars as filedprincipal
WAYFAIR INC94419LAP6NOTE 3.250% 9/15,100,000$5,512,485dollars as filedprincipal
CYTOKINETICS INC23282WAC4NOTE 3.500% 7/04,500,000$5,489,370dollars as filedprincipal

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002033031-25-000001this filing2025-02-13acceptance time not in the bulk data set